Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
134M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
3.42M
-
Shares change
-
+398K
-
Total reported value, excl. options
-
$4.24M
-
Value change
-
+$494K
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$1.27
Significant Holders of NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) as of Q2 2024
19 filings reported holding NKGN - NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.42M shares
of 134M outstanding shares and own 2.55% of the company stock.
Largest 10 shareholders include METEORA CAPITAL, LLC (1.17M shares), Polar Asset Management Partners Inc. (1.08M shares), UNIVERSITY OF CHICAGO (550K shares), Diametric Capital, LP (333K shares), GEODE CAPITAL MANAGEMENT, LLC (68.4K shares), VANGUARD GROUP INC (53.8K shares), UBS Group AG (43.8K shares), NORTHERN TRUST CORP (29.1K shares), Virtu Financial LLC (18.9K shares), and Sequoia Financial Advisors, LLC (18.5K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.